Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riste

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Vaccines|April 30, 2021
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy <i>M.tb</i>-Infected AdultsMichael Riste, Julia L Marshall, Iman Satti, et al.
The Lancet. Infectious Diseases|April 15, 2024
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trialIman Satti, Julia L Marshall, Stephanie A Harris, et al.
The Journal of Infection|June 4, 2026
Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United KingdomEmma C Carter, Cristina Fernandez, Charlotte Lim, et al.
Journal of Translational Medicine|May 15, 2022
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-NorwayÅslaug Helland, Hege G Russnes, Gro Live Fagereng, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Vaccines|April 30, 2021
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy <i>M.tb</i>-Infected AdultsMichael Riste, Julia L Marshall, Iman Satti, et al.
The Lancet. Infectious Diseases|April 15, 2024
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trialIman Satti, Julia L Marshall, Stephanie A Harris, et al.
The Journal of Infection|June 4, 2026
Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United KingdomEmma C Carter, Cristina Fernandez, Charlotte Lim, et al.
Journal of Translational Medicine|May 15, 2022
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-NorwayÅslaug Helland, Hege G Russnes, Gro Live Fagereng, et al.
Pageof 10